Ginkgo Bioworks Holdings Inc (OTCPK:DNABW)
$ 0.00040 (0%) Market Cap: 0 Enterprise Value: 0 PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 67/100

Q2 2026 Ginkgo Bioworks Holdings Inc Earnings Call Transcript

Aug 05, 2026 / 08:30PM GMT
Daniel Marshall
Ginkgo Bioworks Holdings Inc - Senior Manager of Communications and ownership

I'm Daniel Marshall, Senior Manager of Communications and ownership. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Cohen, our CFO. Thanks, as always, for joining us. We're looking forward to updating you on our progress.

As a reminder, during the presentation today, we will be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the SEC to learn more about these risks and uncertainties, including our most recent 10-K.

Today, in addition to updating you on the quarter results, we're going to make the argument that autonomous labs are an imperative for American Science. We're also going to provide insight into how we are going to scale the capabilities of Nebula, our autonomous lab in Boston, and share an update on how we are getting autonomous labs like enhance the next generation of scientists. As usual, we'll end with the Q&A session, and I'll take questions from analysts, investors, and the public can submit those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot